Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Desai

Showing results (101-110 of 179) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
JNCI Cancer Spectrum|April 28, 2020
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic IndexDaphne Day, Christina Guo, Yada Kanjanapan, et al.
Frontiers in Oncology|March 28, 2025
Mapping MAGE-A4 expression in solid cancers for targeted therapiesChristin Habigt, Sylvie Rottey, Iben Spanggaard, et al.
Clinical & Translational Immunology|September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survivalRosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Communications Medicine|July 20, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancerChen Li, Ana Ferro, Shivani K Mhatre, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
Asia-Pacific Journal of Clinical Oncology|November 4, 2025
Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in AustraliaAdel Shahnam, Jeremy Lewin, Anne Hamilton, et al.
Journal of Personalized Medicine|February 23, 2024
Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with SarcomaEden C Andrew, Jeremy Lewin, Jayesh Desai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumorsJayesh Desai, Sridhar Shankar, Michael C Heinrich, et al.
Pageof 18

Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
JNCI Cancer Spectrum|April 28, 2020
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic IndexDaphne Day, Christina Guo, Yada Kanjanapan, et al.
Frontiers in Oncology|March 28, 2025
Mapping MAGE-A4 expression in solid cancers for targeted therapiesChristin Habigt, Sylvie Rottey, Iben Spanggaard, et al.
Clinical & Translational Immunology|September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survivalRosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Communications Medicine|July 20, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancerChen Li, Ana Ferro, Shivani K Mhatre, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
Asia-Pacific Journal of Clinical Oncology|November 4, 2025
Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in AustraliaAdel Shahnam, Jeremy Lewin, Anne Hamilton, et al.
Journal of Personalized Medicine|February 23, 2024
Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with SarcomaEden C Andrew, Jeremy Lewin, Jayesh Desai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumorsJayesh Desai, Sridhar Shankar, Michael C Heinrich, et al.
Pageof 18